Financials
- Market Capitalization 15.92 M
- Employee 23
- Founded 2007
- CEO N/A
- Website www.citiuspharma.com
- Headquarter Nevada, United States
- FIGI BBG001QQH2N3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.36
ratio cours/chiffre d'affaires
1.92
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4621 | CYCN Cyclerion Therapeutics, Inc. - Common Stock | 3.68 USD | -2.90% | -6.36% | +7.92% | +47.20% | 17.23 M USD | ||
| 4624 | PLUR Pluri Inc. - Common Stock | 1.57 USD | +2.61% | -5.42% | +1.29% | -58.92% | 16.94 M USD | ||
| 4646 | NCEL NewcelX Ltd. - Ordinary Shares | 3.31 USD | +3.76% | -5.16% | -8.31% | -34.84% | 15.88 M USD | ||
| 4648 | TPST Tempest Therapeutics, Inc. - Common Stock | 1.06 USD | 0.00% | -7.02% | +19.10% | -55.65% | 15.70 M USD |